Risk Factors for Candida tropicalis Fungemia in Patients with Cancer
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The risk factors for and presentation of Candida tropicalis fungemia, in comparison with those of Candida albicans, have been incompletely characterized. We compared 43 cases of C. tropicalis fungemia with 148 cases of C. albicans fungemia. In univariate analysis, patients with C. tropicalis fungemia were more likely to have leukemia (P=.0006), prolonged neutropenia (P=.03), and a positive blood culture for more days (P=.02). The 2 groups did not differ with regard to baseline Acute Physiology and Chronic Health Evaluation (APACHE) II score, frequency of catheter-associated fungemia, or response to antifungals. In multivariate analysis, patients with C. tropicalis fungemia were more likely to have leukemia (P=.02), previous neutropenia (P=.002), and a longer stay in the intensive care unit during the infectious episode (P=.01). Also, the response of the breakthrough C. tropicalis fungemia was lower (P=.05). In conclusion, the host determinants associated with susceptibility to C. tropicalis are leukemia and prolonged neutropenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality.
Fraser, V. J., Jones, M., Dunkel, J., Storfer, S., Medoff, G., & Dunagan, W. C. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.3.414 · Cited by 679
Viscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514731 · Cited by 601
Importance of Candida Species Other than C. albicans as Pathogens in Oncology Patients
Wingard, J. R. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.1.115 · Cited by 542 · cited 4×
“tropicalis was illustrated by the observation that as many as 60%–80% of colonized patients with neutropenia eventually develop invasive infection [1, 10].”
BackgroundResultInfluentialKao, A. S., Brandt, M. E., Pruitt, W. R., Conn, L. A., Perkins, B. A., Stephens, D. S., Baughman, W. S., Reingold, A. L., Rothrock, G. A., Pfaller, M. A., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/313450 · Cited by 457
Pfaller, M. A., Jones, R. N., Doern, G. V., Sader, H. S., Messer, S. A., Houston, A., Coffman, S., Hollis, R. J., & The SENTRY Participant Group (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.747-751.2000 · Cited by 378
Nguyen, M. H. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430220087009 · Cited by 363
Predictors of Adverse Outcome in Cancer Patients with Candidemia
Anaissie, E. J., Rex, J. H., Uzun, Ö., & Vartivarian, S. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00030-8 · Cited by 295
White, M. H. (1997) · Clinical Infectious Diseases · doi:10.1086/513661 · Cited by 151
Experimental Induction of Fluconazole Resistance in Candida tropicalis ATCC 750
Barchiesi, F., Calabrese, D., Sanglard, D., Falconi Di Francesco, L., Caselli, F., Giannini, D., Giacometti, A., Gavaudan, S., & Scalise, G. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1578-1584.2000 · Cited by 145 · cited 1×
“tropicalis has been shown to rapidly acquire a stable, broad spectrum of resistance to azoles after exposure to increasing concentrations of fluconazole in vitro through upregulation of efflux transporters [21].”
BackgroundSt-Germain, G., Laverdière, M., Pelletier, R., Bourgault, A.-M., Libman, M., Lemieux, C., & Noël, G. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.3.949-953.2001 · Cited by 134 · cited 2×
“This trend also coincided with the emergence of other non-albicans Candida species resistant to fluconazole, both in our institution and elsewhere [4, 8, 22–25].”
BackgroundResult
Cited by
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
Silva, S., Negri, M., Henriques, M., Oliveira, R., Williams, D. W., & Azeredo, J. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00278.x · Cited by 969
Epidemiology of Invasive Mycoses in North America
Pfaller, M. A., & Diekema, D. J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903241444 · Cited by 901
Glucocorticoids and invasive fungal infections
Lionakis, M. S., & Kontoyiannis, D. P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14904-5 · Cited by 669
Self-citationInvasive Fungal Pathogens: Current Epidemiological Trends
Pfaller, M. A., Pappas, P. G., & Wingard, J. R. (2006) · Clinical Infectious Diseases · doi:10.1086/504490 · Cited by 448
Secreted proteases from pathogenic fungi
Monod, M., Capoccia, S., Léchenne, B., Zaugg, C., Holdom, M., & Jousson, O. (2002) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00223 · Cited by 381
Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole
Kothavade, R. J., Kura, M. M., Valand, A. G., & Panthaki, M. H. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.013227-0 · Cited by 340
Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention
Alangaden, G. J. (2011) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2010.11.003 · Cited by 337
Hachem, R., Hanna, H., Kontoyiannis, D., Jiang, Y., & Raad, I. (2008) · Cancer · doi:10.1002/cncr.23466 · Cited by 331
Self-citationAn Update on Candida tropicalis Based on Basic and Clinical Approaches
Zuza-Alves, D. L., Silva-Rocha, W. P., & Chaves, G. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01927 · Cited by 295
Corticosteroid-Induced Adverse Events in Adults: Frequency, Screening and Prevention
Fardet, L., Kassar, A., Cabane, J., & Flahault, A. (2007) · Drug Safety · doi:10.2165/00002018-200730100-00005 · Cited by 254
National Surveillance of Fungemia in Denmark (2004 to 2009)
Arendrup, M. C., Bruun, B., Christensen, J. J., Fuursted, K., Johansen, H. K., Kjældgaard, P., Knudsen, J. D., Kristensen, L., Møller, J., Nielsen, L., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01811-10 · Cited by 223
Dimopoulos, G., Ntziora, F., Rachiotis, G., Armaganidis, A., & Falagas, M. E. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181607262 · Cited by 189
“, but also to a failure of host-defense mechanisms and to complications associated with the patient’s underlying disease.(35) The more severely ill patients are at higher risk for Candida infection and have a worse prognosis.”
BackgroundManagement of central venous catheters in patients with cancer and candidemia
Raad, I., Hanna, H., Boktour, M., Girgawy, E., Danawi, H., Mardani, M., Kontoyiannis, D., Darouiche, R., Hachem, R., & Bodey, G. P. (2004) · Clinical Infectious Diseases · doi:10.1086/382874 · Cited by 159
Self-citationMechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China
Jiang, C., Dong, D., Yu, B., Cai, G., Wang, X., Ji, Y., & Peng, Y. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks481 · Cited by 153
The Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal Pathogens
Arastehfar, A., Lass-Flörl, C., Garcia-Rubio, R., Daneshnia, F., Ilkit, M., Boekhout, T., Gabaldon, T., & Perlin, D. S. (2020) · Journal of Fungi · doi:10.3390/jof6030138 · Cited by 145
Insights into Candida tropicalis nosocomial infections and virulence factors
Negri, M., Silva, S., Henriques, M., & Oliveira, R. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1455-z · Cited by 132
“tropicalis have not been yet fully elucidated [20, 21, 64, 65, 77].”
BackgroundForastiero, A., Mesa-Arango, A. C., Alastruey-Izquierdo, A., Alcazar-Fuoli, L., Bernal-Martinez, L., Pelaez, T., Lopez, J. F., Grimalt, J. O., Gomez-Lopez, A., Cuesta, I., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00477-13 · Cited by 131
“albicans, particularly in neutropenic and oncology patients (2, 9, 10).”
BackgroundChi, H.-W., Yang, Y.-S., Shang, S.-T., Chen, K.-H., Yeh, K.-M., Chang, F.-Y., & Lin, J.-C. (2011) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2010.08.010 · Cited by 103
Extracellular proteinases of Candida species pathogenic yeasts
Rapala‐Kozik, M., Bochenska, O., Zajac, D., Karkowska‐Kuleta, J., Gogol, M., Zawrotniak, M., & Kozik, A. (2018) · Molecular Oral Microbiology · doi:10.1111/omi.12206 · Cited by 94
Evasion of Immune Surveillance in Low Oxygen Environments Enhances Candida albicans Virulence
Lopes, J. P., Stylianou, M., Backman, E., Holmberg, S., Jass, J., Claesson, R., & Urban, C. F. (2018) · mBio · doi:10.1128/mbio.02120-18 · Cited by 88
“albicans infections are not clearly associated with neutropenia (54).”
Davis, S. L., Vazquez, J. A., & Mckinnon, P. S. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1h516 · Cited by 71
Invasive fungal infections in acute leukemia
Bhatt, V. R., Viola, G. M., & Ferrajoli, A. (2011) · Therapeutic Advances in Hematology · doi:10.1177/2040620711410098 · Cited by 71
Chong, Y., Ito, Y., Kamimura, T., Shimoda, S., Miyamoto, T., Akashi, K., Yakushiji, H., & Shimono, N. (2012) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0412-9 · Cited by 35
“have been reported to be significantly higher in patients with hematological malignancies compared to rates in those with other diseases [11–13].”
BackgroundResultAlp, S., Arikan‐Akdagli, S., Gulmez, D., Ascioglu, S., Uzun, O., & Akova, M. (2015) · Mycoses · doi:10.1111/myc.12349 · Cited by 32
Antifungal potential of eugenyl acetate against clinical isolates of Candida species
Musthafa, K. S., Hmoteh, J., Thamjarungwong, B., & Voravuthikunchai, S. P. (2016) · Microbial Pathogenesis · doi:10.1016/j.micpath.2016.07.012 · Cited by 28
Metadata
- Authors
- Kontoyiannis, D. P., Vaziri, I., Hanna, H. A., Boktour, M., Thornby, J., Hachem, R., Bodey, G. P., & Raad, I. I.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-11-15
- Volume
- 33
- Issue
- 10
- Pages
- 1676-1681
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2106042067
- Cited by
- 143
- References
- 10
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.